Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec 6;14(12):1679-1681.
doi: 10.2215/CJN.12621019. Epub 2019 Oct 31.

Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports

Christopher A Carlos  1 , Raymond K Hsu
Affiliations
Editorial

Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports

Christopher A Carlos et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: B7-1H antigen; CTLA4 antigen; acute renal failure; adaptive immunity; cancer; cytoxic T-lymphocytes; hematologic neoplasms; human CD274 protein; human CTLA4 protein; immunotherapy; programmed cell death 1 receptor; tumor microenvironment.

PubMed Disclaimer

Comment on

References

    1. Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, Le DT, Lipson EJ, Glezerman IG, Wolchok J, Cornell LD, Feldman P, Stokes MB, Zapata SA, Hodi FS, Ott PA, Yamashita M, Leaf DE: Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int 90: 638–647, 2016 - PMC - PubMed
    1. Wanchoo R, Karam S, Uppal NN, Barta VS, Deray G, Devoe C, Launay-Vacher V, Jhaveri KD; Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors : Adverse renal effects of immune checkpoint inhibitors: A narrative review. Am J Nephrol 45: 160–169, 2017 - PubMed
    1. Sznol M, Ferrucci PF, Hogg D, Atkins MB, Wolter P, Guidoboni M, Lebbé C, Kirkwood JM, Schachter J, Daniels GA, Hassel J, Cebon J, Gerritsen W, Atkinson V, Thomas L, McCaffrey J, Power D, Walker D, Bhore R, Jiang J, Hodi FS, Wolchok JD: Pooled analysis safety profile of nivolumab and ipilimumab combination therapy in patients with advanced melanoma. J Clin Oncol 35: 3815–3822, 2017 - PubMed
    1. Postow MA, Sidlow R, Hellmann MD: Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378: 158–168, 2018 - PubMed
    1. Seethapathy H, Zhao S, Chute DF, Zubiri L, Oppong Y, Strohbehn I, Cortazar FB, Leaf DE, Mooradian MJ, Villani A-C, Sullivan RJ, Reynolds K, Sise ME: The incidence, causes, and risk factors of acute kidney injury in patients receiving immune checkpoint inhibitors. Clin J Am Soc Nephrol 14: 1692–1700, 2019 - PMC - PubMed

Substances